Development of omics‐based protocols for the microbiological characterization of multi‐strain formulations marketed as probiotics: the case of VSL#3
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Summary: The growing commercial interest in multi‐strain formulations marketed as probiotics has not been accompanied by an equal increase in the evaluation of quality levels of these biotechnological products. The multi‐strain product VSL#3 was used as a model to setup a microbiological characterization that could be extended to other formulations with high complexity. Shotgun metagenomics by deep Illumina sequencing was applied to DNA isolated from the commercial VSL#3 product to confirm strains identity safety and composition. Single‐cell analysis was used to evaluate the cell viability, and β‐galactosidase and urease activity have been used as marker to monitor the reproducibility of the production process. Similarly, these lots were characterized in detail by a metaproteomics approach for which a robust protein extraction protocol was combined with advanced mass spectrometry. The results identified over 1600 protein groups belonging to all strains present in the VSL#3 formulation. Of interest, only 3.2 % proteins showed significant differences mainly related to small variations in strain abundance. The protocols developed in this study addressed several quality criteria that are relevant for marketed multi‐strain products and these represent the first efforts to define the quality of complex probiotic formulations such as VSL#3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kankainen, M., Paulin, L., Tynkkynen, S., von Ossowski, I., Reunanen, J., Partanen, P., Satokari, R., Vesterlund, S., Hendrickx, A. P. A., Lebeer, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908876106 · Cited by 740 · cited 1×
“#3 metagenome should be further validated for each strain, these cell envelope proteins are known to be involved in adhesion to the intestinal epithelium in well-characterized probiotic strains, such as L. rhamnosus GG and B. breve UCC2003 (Kankainen et al., 2009; O’Connell Motherway et al., 2011).”
BackgroundTaverniti, V., & Guglielmetti, S. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0218-x · Cited by 703 · cited 1×
“It should be stressed that in some cases dead cells can maintain the probiotic effects exerted by live cells, as reported in studies with cell cultures, animals and human volunteers (Taverniti and Guglielmetti, 2011; De Almada et al., 2016).”
ResultFunctional Analysis of Putative Adhesion Factors in Lactobacillus acidophilus NCFM
Buck, B. L., Altermann, E., Svingerud, T., & Klaenhammer, T. R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8344-8351.2005 · Cited by 390
O'Connell Motherway, M., Zomer, A., Leahy, S. C., Reunanen, J., Bottacini, F., Claesson, M. J., O'Brien, F., Flynn, K., Casey, P. G., Moreno Munoz, J. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105380108 · Cited by 376
LoCascio, R. G., Desai, P., Sela, D. A., Weimer, B., & Mills, D. A. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.00675-10 · Cited by 229
Kolaček, S., Hojsak, I., Berni Canani, R., Guarino, A., Indrio, F., Orel, R., Pot, B., Shamir, R., Szajewska, H., Vandenplas, Y., et al. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001603 · Cited by 224
Improving End-User Trust in the Quality of Commercial Probiotic Products
Jackson, S. A., Schoeni, J. L., Vegge, C., Pane, M., Stahl, B., Bradley, M., Goldman, V. S., Burguière, P., Atwater, J. B., & Sanders, M. E. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00739 · Cited by 192 · cited 4×
“…published by John Wiley & Sons Ltd and Society for Applied Microbiology., Microbial Biotechnology, 12, 1371–1386 There are presently no accepted guidelines to control the quality of the commercialized probiotic products in spite of the demand for these (Kolacêk et al., 2017; Jackson et al., 2019).”
BackgroundInfluentialBarrangou, R., Briczinski, E. P., Traeger, L. L., Loquasto, J. R., Richards, M., Horvath, P., Coûté-Monvoisin, A.-C., Leyer, G., Rendulic, S., Steele, J. L., et al. (2009) · Journal of Bacteriology · doi:10.1128/jb.00155-09 · Cited by 150 · cited 1×
“However, the metagenomic analysis allowed their identification based on their SNP designation reported previously (Barrangou et al., 2009; Milani et al., 2013), and the SNP abundance was used to estimate their relative abundance (Table 2).”
MethodMorovic, W., Hibberd, A. A., Zabel, B., Barrangou, R., & Stahl, B. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01747 · Cited by 99 · cited 3×
“…and reproduction in any medium, provided the original work is properly cited. bs_bs_banner relevant since some studies have found that commercial products did not contain the declared viable cell numbers (Ibrahim and Carr, 2006; Lin et al., 2006; Drago et al., 2010; Morovic et al., 2016).”
Background
Cited by
Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health
Mazziotta, C., Tognon, M., Martini, F., Torreggiani, E., & Rotondo, J. C. (2023) · Cells · doi:10.3390/cells12010184 · Cited by 889
Global analysis of clinical trials with probiotics
Dronkers, T. M. G., Ouwehand, A. C., & Rijkers, G. T. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04467 · Cited by 119
“VSL#3, a consortium of 3 different bifidobacteria, 4 lactobacilli, and 1 Streptococcus thermophilus strain (Mora et al., 2019), was the most registered multispecies preparation in 74 studies (see also below).”
BackgroundProbiotics in inflammatory bowel disease: Does it work?
Silva, N. O. E., Brito, B. B. D., Silva, F. A. F. D., Santos, M. L. C., & Melo, F. F. D. (2020) · World Journal of Meta-Analysis · doi:10.13105/wjma.v8.i2.54 · Cited by 17
Metadata
- Authors
- Mora, D., Filardi, R., Arioli, S., Boeren, S., Aalvink, S., & de Vos, W. M.
- Venue
- Microbial Biotechnology
- Publisher
- Wiley
- Published
- 2019-08-12
- Volume
- 12
- Issue
- 6
- Pages
- 1371-1386
- ISSN
- 1751-7915 (ISSN-L)
- OpenAlex
- W2968218656
- Cited by
- 45
- References
- 9
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.